Identification of a negative cis element within the ZII domain of the Epstein-Barr virus lytic switch BZLF1 gene promoter.
The Epstein-Barr virus (EBV) lytic switch gene, BZLF1, is tightly regulated in latently infected B cells. The BZLF1 gene promoter (Zp) contains several cis elements that have been previously shown to respond to inducers of the viral lytic cycle. These include four copies of an element referred to as the ZI domains and an element that contains a consensus CRE/AP-1 motif (ZII domain). In addition, Zp is autoregulated through two sites that bind the BZLF1 gene product Zta. The ZI domains have been shown to bind the ubiquitous cellular transcription factors Sp1 and Sp3 and/or the myocyte enhancer factor 2D (Liu et al., EMBO J. 16:143-153, 1997; Liu et al., Virology 228:9-16, 1997). Here we present a functional analysis of the ZII domain and show: (i) ATF-1 and ATF-2 appear to be the predominant cellular factors that bind to the CRE/AP-1 motif present in the ZII domain; and (ii) the region immediately upstream of the CRE/AP-1 motif contains a potent negative cis element, mutation of which results in a >10-fold increase in Zp activity. The negative cis element (ZIIR) in the ZII domain decreases both basal and induced Zp activity and thus is likely to play an important role in regulating reactivation of EBV. In addition, analysis of heterologous promoter constructs indicates that the function of ZIIR is context sensitive. Attempts to demonstrate a cellular factor binding to ZIIR have been unsuccessful, leaving unresolved the mechanism by which repression is mediated.
Liu
P
P
Departments of Pathology and Molecular Microbiology and Division of Molecular Oncology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Liu
S
S
Speck
S H
SH
D051697:Activating Transcription Factor 1; D051698:Activating Transcription Factor 2; D001483:Base Sequence; D017362:Cyclic AMP Response Element-Binding Protein / Q000378:metabolism; D004279:DNA, Viral; D004268:DNA-Binding Proteins / Q000235:genetics*; D004854:Herpesvirus 4, Human / Q000235:genetics*; D015759:Ionomycin / Q000494:pharmacology; D009154:Mutation; D011401:Promoter Regions, Genetic; D011485:Protein Binding; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D015534:Trans-Activators / Q000235:genetics*; D014157:Transcription Factors / Q000378:metabolism; D014407:Tumor Cells, Cultured; D014764:Viral Proteins
D051697:Activating Transcription Factor 1; D051698:Activating Transcription Factor 2; C063676:BZLF1 protein, Herpesvirus 4, Human; D017362:Cyclic AMP Response Element-Binding Protein; D004279:DNA, Viral; D004268:DNA-Binding Proteins; D015534:Trans-Activators; D014157:Transcription Factors; D014764:Viral Proteins; D015759:Ionomycin; D013755:Tetradecanoylphorbol Acetate